Orange Book product · Brand (NDA)
FOSRENOL
LANTHANUM CARBONATE
At a glance
Sep 24, 2014
Approved
Brand (NDA)
Application
Not listed
TE code
2
Listed patents
Key dates
Approval
FDA approval date of this drug product.
Sep 24, 2014
11 yr 11 mo ago
Today
Patent 8980327 expires
Listed drug product patent expiration.
Dec 01, 2030
in 4 yr 6 mo
Patent 9023397 expires
Listed drug product patent expiration.
Dec 01, 2030
in 4 yr 6 mo
Pharmaceutical detail
Active ingredient
LANTHANUM CARBONATE
Strength
EQ 750MG BASE
Dosage form
POWDER
Route
ORAL
TE code
Not listed
Application
NDA 204734
Product number
001
Marketing status
RX
Reference listed drug (RLD)
Yes
Reference standard (RS)
No
Active-ingredient family
View full familyThis is a reference-listed drug (RLD) — the basis for generic (ANDA) applications. Other products sharing this ingredient are listed below.
- 2005FOSRENOLBrand (NDA)
NDA 021468 · TAKEDA PHARMS USA
- 2025LANTHANUM CARBONATEGeneric (ANDA)
ANDA 202329 · ALKEM LABS LTD
- 2022LANTHANUM CARBONATEGeneric (ANDA)
ANDA 090977 · BARR
- 2022LANTHANUM CARBONATEGeneric (ANDA)
ANDA 206868 · INVAGEN PHARMS
- 2017LANTHANUM CARBONATEGeneric (ANDA)
ANDA 090978 · NATCO PHARMA LTD
Listed patents (2)
| Patent | Expires | In | Type |
|---|---|---|---|
| 8980327 | Dec 01, 2030 | in 4 yr 6 mo | Product |
| 9023397 | Dec 01, 2030 | in 4 yr 6 mo | Product |

